Expression of cancer-testis antigens in esophageal cancer and their progress in immunotherapy.

ABSTRACT:

Purpose

Esophageal cancer is a common disease in China with low survival rate due to no obvious early symptoms and lack of effective screening strategies. Traditional treatments usually do not produce desirable results in patients with advanced esophageal cancer, so immunotherapy which relies on tumor-related antigens is needed to combat low survival rates effectively. Cancer-testis antigens (CTA), a large family of tumor-related antigens, have a strong in vivo immunogenicity and tumor-restricted expressing patterns in normal adult tissues. These two characteristics are ideal features of anticancer immunotherapy targets and, therefore, promoted the development of some studies of CTA-based therapy. To provide ideas for the role of the cancer-testis antigens MAGE-A, NY-ESO-1, LAGE-1,

SUBMITTER: Zhang Y 

PROVIDER: S-EPMC6373256 | biostudies-literature | 2019 Feb

REPOSITORIES: biostudies-literature